322 related articles for article (PubMed ID: 27356955)
21. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway.
Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB
J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837
[TBL] [Abstract][Full Text] [Related]
22. Bcl-xL overexpression and its association with the progress of tongue carcinoma.
Zhang K; Jiao K; Xing Z; Zhang L; Yang J; Xie X; Yang L
Int J Clin Exp Pathol; 2014; 7(11):7360-77. PubMed ID: 25550772
[TBL] [Abstract][Full Text] [Related]
23. The interplay of matrix metalloproteinase-8, transforming growth factor-β1 and vascular endothelial growth factor-C cooperatively contributes to the aggressiveness of oral tongue squamous cell carcinoma.
Åström P; Juurikka K; Hadler-Olsen ES; Svineng G; Cervigne NK; Coletta RD; Risteli J; Kauppila JH; Skarp S; Kuttner S; Oteiza A; Sutinen M; Salo T
Br J Cancer; 2017 Sep; 117(7):1007-1016. PubMed ID: 28772283
[TBL] [Abstract][Full Text] [Related]
24. Molecular characterisation in tongue squamous cell carcinoma reveals key variants potentially linked to clinical outcomes.
Alsofyani AA; Dallol A; Farraj SA; Alsiary RA; Samkari A; Alhaj-Hussain BT; Khan JA; Al-Maghrabi J; Al-Khayyat SS; Alkhatabi H; Elaimi A; Buhmeida A; Johargy AK; Abuzenadah AM; Azhar EI; Al-Qahtani MH
Cancer Biomark; 2020; 28(2):213-220. PubMed ID: 32250288
[TBL] [Abstract][Full Text] [Related]
25. [The expression and clinical significance of BATF2 in oral tongue squamous cell carcinoma].
Wen H; Tang J; Liu B; Sun C
Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Jan; 50(1):13-7. PubMed ID: 25779069
[TBL] [Abstract][Full Text] [Related]
26. Appraising Oncogenic Long Noncoding RNAs as Novel Biomarkers for Oral Tongue Squamous Cell Carcinoma: a Meta-Analysis.
Cheng Y; Wang Y; Cui Z; Lin D; Zheng M; Cheng H
Clin Lab; 2019 Sep; 65(9):. PubMed ID: 31532111
[TBL] [Abstract][Full Text] [Related]
27. Reduced expression of liver kinase B1 and Beclin1 is associated with the poor survival of patients with non-small cell lung cancer.
Jiang L; Liang X; Liu M; Wang W; Ma J; Guo Q; Han L; Yang C; Nan K
Oncol Rep; 2014 Nov; 32(5):1931-8. PubMed ID: 25175672
[TBL] [Abstract][Full Text] [Related]
28. PTK7 is a molecular marker for metastasis, TNM stage, and prognosis in oral tongue squamous cell carcinoma.
Dong Y; Chen X; Li H; Ni Y; Han W; Wang J
Pol J Pathol; 2017; 68(1):49-54. PubMed ID: 28547980
[TBL] [Abstract][Full Text] [Related]
29. Limonin suppresses the progression of oral tongue squamous cell carcinoma via inhibiting YAP transcriptional regulatory activity.
Yang G; Li Z; Chen L
Tissue Cell; 2020 Aug; 65():101346. PubMed ID: 32746992
[TBL] [Abstract][Full Text] [Related]
30. FNDC3B promotes epithelial-mesenchymal transition in tongue squamous cell carcinoma cells in a hypoxic microenvironment.
Zhong Z; Zhang H; Hong M; Sun C; Xu Y; Chen X; Gao C; He M; Liu W; Liang J
Oncol Rep; 2018 Apr; 39(4):1853-1859. PubMed ID: 29393475
[TBL] [Abstract][Full Text] [Related]
31. Aberrant expression of PHLPP1 and PHLPP2 correlates with poor prognosis in patients with hypopharyngeal squamous cell carcinoma.
Zhou J; Yu X; Wang J; Li T; Jin T; Lei D; Pan X
PLoS One; 2015; 10(3):e0119405. PubMed ID: 25793736
[TBL] [Abstract][Full Text] [Related]
32. FRMD4A: A potential therapeutic target for the treatment of tongue squamous cell carcinoma.
Zheng X; Jia B; Lin X; Han J; Qiu X; Chu H; Sun X; Hu W; Pan J; Chen J; Zhao J
Int J Mol Med; 2016 Nov; 38(5):1443-1449. PubMed ID: 27666346
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis.
Wei Z; Wang Y; Li Z; Yuan C; Zhang W; Wang D; Ye J; Jiang H; Wu Y; Cheng J
J Oral Pathol Med; 2013 Nov; 42(10):747-54. PubMed ID: 23551691
[TBL] [Abstract][Full Text] [Related]
34. Expression levels of cleaved caspase-3 and caspase-3 in tumorigenesis and prognosis of oral tongue squamous cell carcinoma.
Liu PF; Hu YC; Kang BH; Tseng YK; Wu PC; Liang CC; Hou YY; Fu TY; Liou HH; Hsieh IC; Ger LP; Shu CW
PLoS One; 2017; 12(7):e0180620. PubMed ID: 28700659
[TBL] [Abstract][Full Text] [Related]
35. Prognostic evaluation of oral tongue cancer: means, markers and perspectives (II).
Bello IO; Soini Y; Salo T
Oral Oncol; 2010 Sep; 46(9):636-43. PubMed ID: 20637679
[TBL] [Abstract][Full Text] [Related]
36. High expression of the histone demethylase LSD1 associates with cancer cell proliferation and unfavorable prognosis in tongue cancer.
Yuan C; Li Z; Qi B; Zhang W; Cheng J; Wang Y
J Oral Pathol Med; 2015 Feb; 44(2):159-65. PubMed ID: 25040359
[TBL] [Abstract][Full Text] [Related]
37. Neutrophils infiltration in the tongue squamous cell carcinoma and its correlation with CEACAM1 expression on tumor cells.
Wang N; Feng Y; Wang Q; Liu S; Xiang L; Sun M; Zhang X; Liu G; Qu X; Wei F
PLoS One; 2014; 9(2):e89991. PubMed ID: 24587171
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of SIP1 and downregulation of E-cadherin predict delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma after partial glossectomy.
Sakamoto K; Imanishi Y; Tomita T; Shimoda M; Kameyama K; Shibata K; Sakai N; Ozawa H; Shigetomi S; Fujii R; Fujii M; Ogawa K
Ann Surg Oncol; 2012 Feb; 19(2):612-9. PubMed ID: 21913013
[TBL] [Abstract][Full Text] [Related]
39. Toll-like receptors 2, 4, and 9 in primary, metastasized, and recurrent oral tongue squamous cell carcinomas.
Mäkinen LK; Ahmed A; Hagström J; Lehtonen S; Mäkitie AA; Salo T; Haglund C; Atula T
J Oral Pathol Med; 2016 May; 45(5):338-45. PubMed ID: 26426362
[TBL] [Abstract][Full Text] [Related]
40. A simple novel prognostic model for early stage oral tongue cancer.
Almangush A; Coletta RD; Bello IO; Bitu C; Keski-Säntti H; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Tommola S; Soini Y; Kosma VM; Koivunen P; Kowalski LP; Nieminen P; Grénman R; Leivo I; Salo T
Int J Oral Maxillofac Surg; 2015 Feb; 44(2):143-50. PubMed ID: 25457829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
